MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9

Maron, 2013, Hypertrophic cardiomyopathy, Lancet, 381, 242, 10.1016/S0140-6736(12)60397-3 Ishii, 2006, Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction, J. Hum. Genet., 51, 1087, 10.1007/s10038-006-0070-9 Kumarswamy, 2014, Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure, Circ. Res., 114, 1569, 10.1161/CIRCRESAHA.114.303915 Song, 2019, MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3, Biochem. Biophys. Res. Commun., 519, 682, 10.1016/j.bbrc.2019.09.035 Jiang, 2016, Long non-coding RNA-ROR mediates the reprogramming in cardiac hypertrophy, PloS One, 11 Li, 2017, LncRNA myocardial infarction-associated transcript (MIAT) contributed to cardiac hypertrophy by regulating TLR4 via miR-93, Eur. J. Pharmacol., 818, 508, 10.1016/j.ejphar.2017.11.031 Hu, 2019, Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway, J. Cell Mol. Med., 23, 2505, 10.1111/jcmm.14135 Huang, 2015, Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy, J. Cell Mol. Med., 19, 608, 10.1111/jcmm.12445 Sánchez-Taltavull, 2016, On cross-conditional and fluctuation correlations in competitive RNA networks, Bioinformatics, 32, i790, 10.1093/bioinformatics/btw472 Yamamura, 2017, Interaction and cross-talk between non-coding RNAs, Cell. Mol. Life Sci., 75, 467, 10.1007/s00018-017-2626-6 Zhang, 2019, STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis, Sci. Rep., 9, 460, 10.1038/s41598-018-36369-1 Wang, 2019, SP1-SYNE1-AS1-miR-525-5p feedback loop regulates Ang-II-induced cardiac hypertrophy, J. Cell. Physiol., 234, 14319, 10.1002/jcp.28131 Chen, 2018, The long noncoding RNA XIST protects cardiomyocyte hypertrophy by targeting miR-330-3p, Biochem. Biophys. Res. Commun., 505, 807, 10.1016/j.bbrc.2018.09.135 Hirt, 2015, Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology, J. Mol. Cell. Cardiol., 81, 1, 10.1016/j.yjmcc.2015.01.008 Wang, 2020, NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression, Theranostics, 10, 553, 10.7150/thno.37181 Wang, 2015, MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase, Cell. Physiol. Biochem., 35, 1546, 10.1159/000373970 Chu, 2018, Overexpression of miR-135b attenuates pathological cardiac hypertrophy by targeting CACNA1C, Int. J. Cardiol., 269, 235, 10.1016/j.ijcard.2018.07.016 Nagalingam, 2013, A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling, J. Biol. Chem., 288, 11216, 10.1074/jbc.M112.442384 Marques, 2016, The transcardiac gradient of cardio-microRNAs in the failing heart, Eur. J. Heart Fail., 18, 1000, 10.1002/ejhf.517 Ovchinnikova, 2016, Signature of circulating microRNAs in patients with acute heart failure, Eur. J. Heart Fail., 18, 414, 10.1002/ejhf.332 Mo, 2019, miR-30e-5p mitigates hypoxia-induced apoptosis in human stem cell-derived cardiomyocytes by suppressing bim, Int. J. Biol. Sci., 15, 1042, 10.7150/ijbs.31099 Asakura, 2002, Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy, Nat. Med., 8, 35, 10.1038/nm0102-35 Ren, 2018, A disintegrin and metalloprotease-22 attenuates hypertrophic remodeling in mice through inhibition of the protein kinase B signaling pathway, J Am Heart Assoc, 7, 10.1161/JAHA.117.005696 Tay, 2014, The multilayered complexity of ceRNA crosstalk and competition, Nature, 505, 344, 10.1038/nature12986 Yang, 2018, Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy, Cell Death Dis., 9, 10.1038/s41419-018-1029-4 Li, 2017, Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction, Biochem. Biophys. Res. Commun., 491, 1026, 10.1016/j.bbrc.2017.08.005 Coto, 2017, Differential methylation of lncRNA KCNQ1OT1 promoter polymorphism was associated with symptomatic cardiac long QT, Epigenomics, 9, 1049, 10.2217/epi-2017-0024